Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer

著录项

• 来源
  《中华医学杂志（英文版）》 |2021年第15期|1780-1788|共9页
• 作者

  Ying Cheng; Hui Li; Liang Zhang; Jing-Jing Liu; Chang-Liang Yang; Shuang Zhang;

  展开▼
• 作者单位

  Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin 130012 China;

  Translational Oncology Research Lab Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer Jilin Cancer Hospital Changchun Jilin 130012 China;

  Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin 130012 China;

  Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin 130012 China;

  Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin 130012 China;

  Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin 130012 China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词

• 入库时间 2022-08-19 04:59:25